These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21756549)

  • 21. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
    Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A
    Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants.
    De Marchis GM; Jung S; Colucci G; Meier N; Fischer U; Weck A; Mono ML; Galimanis A; Mattle HP; Schroth G; Gralla J; Arnold M; Brekenfeld C
    Stroke; 2011 Nov; 42(11):3061-6. PubMed ID: 21980194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
    Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign.
    Mattle HP; Arnold M; Georgiadis D; Baumann C; Nedeltchev K; Benninger D; Remonda L; von Büdingen C; Diana A; Pangalu A; Schroth G; Baumgartner RW
    Stroke; 2008 Feb; 39(2):379-83. PubMed ID: 18096842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience.
    Koennecke HC; Nohr R; Leistner S; Marx P
    Stroke; 2001 May; 32(5):1074-8. PubMed ID: 11340212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of routine IV thrombolysis between 3 and 4.5 h after ischemic stroke.
    Uyttenboogaart M; Vroomen PC; Stewart RE; De Keyser J; Luijckx GJ
    J Neurol Sci; 2007 Mar; 254(1-2):28-32. PubMed ID: 17257623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke.
    Medlin F; Amiguet M; Vanacker P; Michel P
    Stroke; 2015 Jan; 46(1):126-31. PubMed ID: 25424477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
    Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of Computed Tomographic Perfusion in Thrombolysis for Minor Stroke.
    Ng FC; Coote S; Frost T; Bladin C; Choi PM
    Stroke; 2016 Jul; 47(7):1914-6. PubMed ID: 27197850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
    Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.